Literature DB >> 1382501

Autocrine role of insulin-like growth factor (IGF)-I in a human thyroid cancer cell line.

N Onoda1, E Ohmura, T Tsushima, Y Ohba, N Emoto, O Isozaki, Y Sato, K Shizume, H Demura.   

Abstract

An established cell line (TC-cell, clone 78) derived from human thyroid papillary cancer cells was investigated for production of peptide growth factors. The cells had specific binding sites for insulin-like growth factor-I (IGF-I) and responded to this growth factor with increased proliferation. Culture medium conditioned by TC cells was found to contain insulin-like growth factor (IGF)-I and IGF-binding protein(s). Furthermore, reverse transcription-polymerase chain reaction revealed expression of IGF-I mRNA. When monoclonal antibody to IGF-I receptors (alpha IR3) was added, the growth of TC cells cultured in serum-free medium was significantly reduced. The growth rate of the cells was restored when the antibody was removed from the medium. These results strongly suggest that TC cells produce IGF-I, which is involved in the regulation of their own growth.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382501     DOI: 10.1016/0959-8049(92)90033-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

1.  Increased thyroid cancer risk in acromegaly.

Authors:  Selcuk Dagdelen; Nese Cinar; Tomris Erbas
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

2.  Insulin-like growth factor-1 is essential to the increased mortality caused by excess growth hormone: a case of thyroid cancer and non-Hodgkin's lymphoma in a patient with pituitary acromegaly.

Authors:  A Taslipinar; E Bolu; L Kebapcilar; M Sahin; G Uckaya; M Kutlu
Journal:  Med Oncol       Date:  2008-07-29       Impact factor: 3.064

Review 3.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

4.  The role of insulin-like growth factor-1 (IGF-1) in follicular thyroid cancer cell line CGTH W-1.

Authors:  J D Lin; Y S Ho; H Y Chang; H F Weng
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-12       Impact factor: 2.416

5.  Insulin-Like Growth Factor I in Human Thyroid Tissue: Specific Localization by Immunohistochemistry and In Situ Hybridization.

Authors:  Rui M. B. Maciel; Edna T. Kimura; Mirian H. Takahaski; Maria-Honorina C. Lopes; Maria-Isabel S. Mesquita; Alan C. Moses; Vania N. Alberti
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

6.  Insulin-like growth factor I receptors and insulin-like growth factor-binding proteins in human parathyroid tumors.

Authors:  R Tanaka; T Tsushima; H Murakami; K Shizume; T Obara
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

7.  Extracellular matrix interactions. 2: Extracellular matrix structure is important for growth factor localization and function.

Authors:  T Golombick; D Dajee; W R Bezwoda
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-05       Impact factor: 2.416

8.  The insulin and igf-I pathway in endocrine glands carcinogenesis.

Authors:  Roberta Malaguarnera; Alaide Morcavallo; Antonino Belfiore
Journal:  J Oncol       Date:  2012-08-08       Impact factor: 4.375

9.  Evidence for mutual interdependence of epithelium and stromal lymphoid cells in a subset of papillary carcinomas.

Authors:  M H Takahashi; G A Thomas; E D Williams
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

10.  AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up.

Authors:  Caterina Mian; Filippo Ceccato; Susi Barollo; Sara Watutantrige-Fernando; Nora Albiger; Daniela Regazzo; Paola de Lazzari; Gianmaria Pennelli; Sandra Rotondi; Davide Nacamulli; Maria Rosa Pelizzo; Marie-Lise Jaffrain-Rea; Franco Grimaldi; Gianluca Occhi; Carla Scaroni
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.